MTM(SH:688029) Xin Lang Cai Jing·2026-02-03 01:32Group 1 - The core viewpoint of the news is that Nanwei Medical has shown significant financial performance with a notable increase in revenue and net profit, alongside active trading in its stocks [2] - As of February 2, Nanwei Medical's stock price decreased by 2.33%, with a trading volume of 169 million yuan, and a net financing purchase of 1.41 million yuan [1] - The company has a financing balance of 486 million yuan, which accounts for 3.31% of its market capitalization, indicating a high level of financing activity [1] Group 2 - For the period from January to September 2025, Nanwei Medical achieved an operating income of 2.381 billion yuan, representing a year-on-year growth of 18.29% [2] - The net profit attributable to the parent company for the same period was 509 million yuan, reflecting a year-on-year increase of 12.90% [2] - The company has distributed a total of 978 million yuan in dividends since its A-share listing, with 664 million yuan distributed over the past three years [2]